Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
125 This is exemplified by immune evasion via antigen loss variants under immunotherapy or secondary mutations in driver oncogenes (e.g., EGFR-T790M, ALK-L1196M, BCR-ABL-T315I) in the context of targeted therapies
inhibiting glucagon release and delaying gastric emptying
Peter Balazs, MD, a hormone and weight-loss specialist serving the New York and New Jersey area, was not involved in the study but reiterated the role of the genetic variants in treatment response and side effects
Advances in experimental medicine and biology , 1032 , 37-53
However, in a studying employing the human-like SCID mouse model, melatonin induced regression of transplanted human endometriotic lesions (166)